Knockdown of LRRK2 results in an attenuated microglial-induced inflammatory cytokine production, while in contrast PD patients show higher levels of activated microglia and an accompanying elevated cytokine response [65,87,88,89]. This evidence concerns the gene LRRK2 and Parkinson disease.